» Authors » Jasper Morgan

Jasper Morgan

Explore the profile of Jasper Morgan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 117
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Razieh C, Powell B, Drummond R, Ward I, Morgan J, Glickman M, et al.
PLoS Med . 2025 Feb; 22(2):e1004507. PMID: 40009587
Background: Electronic health records (EHRs) are increasingly used to investigate health inequalities across ethnic groups. While there are some studies showing that the recording of ethnicity in EHR is imperfect,...
2.
Nafilyan V, Bosworth M, Morgan J, Ayoubkhani D, Dolby T, Groom P, et al.
Int J Epidemiol . 2024 Jan; 53(1). PMID: 38199788
No abstract available.
3.
Nafilyan V, Bermingham C, Ward I, Morgan J, Zaccardi F, Khunti K, et al.
Nat Commun . 2023 Mar; 14(1):1541. PMID: 36973247
Several studies have reported associations between COVID-19 vaccination and risk of cardiac diseases, especially in young people; the impact on mortality, however, remains unclear. We use national, linked electronic health...
4.
Bosworth M, Ahmed T, Larsen T, Lorenzi L, Morgan J, Ali R, et al.
BMC Med . 2023 Jan; 21(1):13. PMID: 36617562
Background: Ethnic minority groups in England have been disproportionately affected by the COVID-19 pandemic and have lower vaccination rates than the White British population. We examined whether ethnic differences in...
5.
Nafilyan V, Morgan J, Mais D, Sleeman K, Butt A, Ward I, et al.
Lancet Reg Health Eur . 2022 Dec; 25:100562. PMID: 36545003
Background: The diagnosis of a severe physical health condition can cause psychological distress and lead to severe depression. The association between severe physical health conditions and the risk of suicide,...
6.
Bermingham C, Morgan J, Ayoubkhani D, Glickman M, Islam N, Sheikh A, et al.
Am J Epidemiol . 2022 Sep; 192(2):267-275. PMID: 36065824
Estimating real-world vaccine effectiveness is vital to assessing the coronavirus disease 2019 (COVID-19) vaccination program and informing the ongoing policy response. However, estimating vaccine effectiveness using observational data is inherently...
7.
Gaughan C, Razieh C, Khunti K, Banerjee A, Chudasama Y, Davies M, et al.
J Public Health (Oxf) . 2022 Feb; 44(4):936. PMID: 35134236
No abstract available.
8.
Gaughan C, Razieh C, Khunti K, Banerjee A, Chudasama Y, Davies M, et al.
J Public Health (Oxf) . 2022 Jan; 45(1):e65-e74. PMID: 34994801
Background: Despite generally high coronavirus disease 2019 (COVID-19) vaccination rates in the UK, vaccination hesitancy and lower take-up rates have been reported in certain ethnic minority communities. Methods: We used...
9.
Nafilyan V, Dolby T, Razieh C, Gaughan C, Morgan J, Ayoubkhani D, et al.
BMJ Open . 2021 Jul; 11(7):e053402. PMID: 34301672
Objective: To examine inequalities in COVID-19 vaccination rates among elderly adults in England. Design: Cohort study. Setting: People living in private households and communal establishments in England. Participants: 6 655...
10.
Nafilyan V, Humberstone B, Mehta N, Diamond I, Coupland C, Lorenzi L, et al.
Lancet Digit Health . 2021 May; 3(7):e425-e433. PMID: 34049834
Background: Public policy measures and clinical risk assessments relevant to COVID-19 need to be aided by risk prediction models that are rigorously developed and validated. We aimed to externally validate...